Moreover, this modified DC function surely transferred to activation and increase of tumor antigen specific CD8+ T cells (SIINFEKL-H-2Kb/Tet+CD8+ T cells), which are primary killing players in the anti-tumor immunity (Figures 4C, D). The gene discussed is CD8A; the disease is neoplasm.